Evidence map›Paper›PMID 35563225›Full record

ArticleInternational journal of molecular sciences2022

Polymerizable Skin Hydrogel for Full Thickness Wound Healing.

Mairobi Persinal-Medina, Sara Llames, Manuel Chacón, Natalia Vázquez, Marta Pevida, Ignacio Alcalde, Sergio Alonso-Alonso, Laura María Martínez-López, Jesús Merayo-Lloves, Álvaro Meana

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mairobi Persinal-MedinaInstituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, 33012 Oviedo, Spain.ORCID 0000-0002-1330-4834
Sara LlamesInstituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, 33012 Oviedo, Spain.ORCID 0000-0001-5456-1389
Manuel ChacónInstituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, 33012 Oviedo, Spain.
Natalia VázquezInstituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, 33012 Oviedo, Spain.ORCID 0000-0002-3410-2190
Marta PevidaInstituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, 33012 Oviedo, Spain.
Ignacio AlcaldeInstituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, 33012 Oviedo, Spain.ORCID 0000-0001-6051-9240
Sergio Alonso-AlonsoInstituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, 33012 Oviedo, Spain.ORCID 0000-0002-1070-0380
Laura María Martínez-LópezInstituto Oftalmológico Fernández-Vega, 33012 Oviedo, Spain.ORCID 0000-0003-3840-1814
Jesús Merayo-LlovesInstituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, 33012 Oviedo, Spain.
Álvaro MeanaInstituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, 33012 Oviedo, Spain.ORCID 0000-0001-9434-6042
Universidad de Oviedo · ESFernández-Vega Ophthalmological Institute · ES

Funding

Instituto de Desarrollo Económico del Principado de Asturias, Gobierno del Principado de Asturias, Fondo Europeo de desarrollo regional, Unión Europea IDE/2016/000189Instituto de Salud Carlos III (ISCIII), Red Española de Terapias Avanzadas (TERAV ISCIII), "NextGenerationEU. Plan de Recuperación Transformación y Resiliencia" RD21/0017/0033Programa Jovellanos Gobierno del Principado de Asturias IDI/2017/000223
6 · The paper itself

Abstract

The skin is the largest organ in the human body, comprising the main barrier against the environment. When the skin loses its integrity, it is critical to replace it to prevent water loss and the proliferation of opportunistic infections. For more than 40 years, tissue-engineered skin grafts have been based on the in vitro culture of keratinocytes over different scaffolds, requiring between 3 to 4 weeks of tissue culture before being used clinically. In this study, we describe the development of a polymerizable skin hydrogel consisting of keratinocytes and fibroblast entrapped within a fibrin scaffold. We histologically characterized the construct and evaluated its use on an in vivo wound healing model of skin damage. Our results indicate that the proposed methodology can be used to effectively regenerate skin wounds, avoiding the secondary in vitro culture steps and thus, shortening the time needed until transplantation in comparison with other bilayer skin models. This is achievable due to the instant polymerization of the keratinocytes and fibroblast combination that allows a direct application on the wound. We suggest that the polymerizable skin hydrogel is an inexpensive, easy and rapid treatment that could be transferred into clinical practice in order to improve the treatment of skin wounds.

Indexed as

HydrogelsSkin, ArtificialFibroblastsHumansSkinSkin TransplantationTissue EngineeringWound HealingHydrogelscellular therapyhydrogelskin regenerationtissue engineering

Identifiers

PMID35563225
PMCPMC9100232
OpenAlexW4225014268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.